Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Interference with transforming growth factor-beta/ Smad3 signaling results in accelerated healing of wounds in previously irradiated skin.

Flanders KC, Major CD, Arabshahi A, Aburime EE, Okada MH, Fujii M, Blalock TD, Schultz GS, Sowers A, Anzano MA, Mitchell JB, Russo A, Roberts AB.

Am J Pathol. 2003 Dec;163(6):2247-57.

2.

Role of Smad3 in the hormonal modulation of in vivo wound healing responses.

Ashcroft GS, Mills SJ, Flanders KC, Lyakh LA, Anzano MA, Gilliver SC, Roberts AB.

Wound Repair Regen. 2003 Nov-Dec;11(6):468-73.

PMID:
14617288
3.

Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation.

Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, Roberts AB.

Am J Pathol. 2002 Mar;160(3):1057-68.

4.

Conditional knockout of the Smad1 gene.

Huang S, Tang B, Usoskin D, Lechleider RJ, Jamin SP, Li C, Anzano MA, Ebendal T, Deng C, Roberts AB.

Genesis. 2002 Feb;32(2):76-9. No abstract available.

PMID:
11857782
5.

The genes encoding geranylgeranyl transferase alpha-subunit and transglutaminase 1 are very closely linked but not functionally related in terminally differentiating keratinocytes.

Song HJ, Rossi A, Ceci R, Kim IG, Anzano MA, Jang SI, De Laurenzi V, Steinert PM.

Biochem Biophys Res Commun. 1997 Jun 9;235(1):10-4.

PMID:
9196026
6.

Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid.

Anzano MA, Peer CW, Smith JM, Mullen LT, Shrader MW, Logsdon DL, Driver CL, Brown CC, Roberts AB, Sporn MB.

J Natl Cancer Inst. 1996 Jan 17;88(2):123-5. No abstract available.

PMID:
8537973
7.

Chemopreventive activity of tamoxifen, N-(4-hydroxyphenyl)retinamide, and the vitamin D analogue Ro24-5531 for androgen-promoted carcinomas of the rat seminal vesicle and prostate.

Lucia MS, Anzano MA, Slayter MV, Anver MR, Green DM, Shrader MW, Logsdon DL, Driver CL, Brown CC, Peer CW, et al.

Cancer Res. 1995 Dec 1;55(23):5621-7.

8.

Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen.

Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB, Sporn MB.

Cancer Res. 1994 Sep 1;54(17):4614-7.

9.

Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.

Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB.

Cancer Res. 1994 Jul 1;54(13):3413-21.

10.

1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.

Anzano MA, Smith JM, Uskoković MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL, et al.

Cancer Res. 1994 Apr 1;54(7):1653-6.

11.

Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading.

Slayter MV, Anzano MA, Kadomatsu K, Smith JM, Sporn MB.

Cancer Res. 1994 Mar 15;54(6):1440-5.

12.

Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle.

Kadomatsu K, Anzano MA, Slayter MV, Winokur TS, Smith JM, Sporn MB.

Cancer Res. 1993 Apr 1;53(7):1480-3.

13.

Structure-function analysis of human transforming growth factor-alpha by site-directed mutagenesis.

Feild JA, Reid RH, Rieman DJ, Kline TP, Sathe G, Greig RG, Anzano MA.

Biochem J. 1992 Apr 1;283 ( Pt 1):91-8.

14.

Antagonism of TGF-alpha receptor binding and TGF-alpha induced stimulation of cell proliferation by methyl pheophorbides.

Rieman DJ, Anzano MA, Chan GW, Imburgia TJ, Chan JA, Johnson RK, Greig RG.

Oncol Res. 1992;4(4-5):193-200.

PMID:
1324032
15.

Characterization and partial purification of human epithelial transforming growth factor.

Dunnington DJ, Scott RG, Anzano MA, Greig R.

J Cell Biochem. 1990 Dec;44(4):229-39.

PMID:
2095367
16.

Tumor necrosis factor-mediated biological activities involve a G-protein-dependent mechanism.

Earl CQ, Stadel JM, Anzano MA.

J Biol Response Mod. 1990 Aug;9(4):361-7.

PMID:
2168471
17.

Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines.

Murthy U, Anzano MA, Greig RG.

Int J Cancer. 1989 Jul 15;44(1):110-5.

PMID:
2545633
18.

Growth factor production by human colon carcinoma cell lines.

Anzano MA, Rieman D, Prichett W, Bowen-Pope DF, Greig R.

Cancer Res. 1989 Jun 1;49(11):2898-904.

19.

Growth-inhibitory activity of interferon-beta against human colorectal carcinoma cell lines.

Wong VL, Rieman DJ, Aronson L, Dalton BJ, Greig R, Anzano MA.

Int J Cancer. 1989 Mar 15;43(3):526-30.

PMID:
2494120
20.

Automation of data acquisition and processing in assays for anchorage-independent growth: application to the purification of epithelial transforming growth factor.

Dunnington DJ, Pinsky S, Mattes D, Prichett W, Earl CQ, Greig R, Anzano MA.

Anal Biochem. 1988 Oct;174(1):257-64.

PMID:
3218737
21.

Coupling of TGF-beta-induced mitogenesis to G-protein activation in AKR-2B cells.

Murthy US, Anzano MA, Stadel JM, Greig R.

Biochem Biophys Res Commun. 1988 May 16;152(3):1228-35.

PMID:
3132155
23.

Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB.

Proc Natl Acad Sci U S A. 1985 Jan;82(1):119-23.

24.

Increased secretion of type beta transforming growth factor accompanies viral transformation of cells.

Anzano MA, Roberts AB, De Larco JE, Wakefield LM, Assoian RK, Roche NS, Smith JM, Lazarus JE, Sporn MB.

Mol Cell Biol. 1985 Jan;5(1):242-7.

25.
26.

Purification and properties of a type beta transforming growth factor from bovine kidney.

Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan YC, Stein S, Lehrman SR, Smith JM, Lamb LC, et al.

Biochemistry. 1983 Dec 6;22(25):5692-8.

PMID:
6607069
27.
28.

Transforming growth factors from neoplastic and nonneoplastic tissues.

Roberts AB, Frolik CA, Anzano MA, Sporn MB.

Fed Proc. 1983 Jun;42(9):2621-6.

PMID:
6303865
29.

Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells.

Anzano MA, Roberts AB, Meyers CA, Komoriya A, Lamb LC, Smith JM, Sporn MB.

Cancer Res. 1982 Nov;42(11):4776-8.

30.

Purification by reverse-phase high-performance liquid chromatography of an epidermal growth factor-dependent transforming growth factor.

Anzano MA, Roberts AB, Smith JM, Lamb LC, Sporn MB.

Anal Biochem. 1982 Sep 1;125(1):217-24. No abstract available.

PMID:
6983313
31.

Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF.

Roberts AB, Anzano MA, Lamb LC, Smith JM, Frolik CA, Marquardt H, Todaro GJ, Sporn MB.

Nature. 1982 Feb 4;295(5848):417-9. No abstract available.

PMID:
6276769
32.

New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues.

Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB.

Proc Natl Acad Sci U S A. 1981 Sep;78(9):5339-43.

33.
36.

Simplified two-step column-chromatographic determination of taurine in urine.

Anzano MA, Naewbanij JO, Lamb AJ.

Clin Chem. 1978 Feb;24(2):321-5.

Supplemental Content

Loading ...
Support Center